Arizona Board of Regents oversees college activities. The company was founded in 1864 and is headquartered in Phoenix, AZ.

Develops and manufactures drugs related to immunology, neurobiology and oncology

Renovo is a biopharmaceutical product company and is a leader in the discovery and development of drugs to reduce scarring, improve wound healing and enhance tissue regeneration. We aim to be first to market with a scar reduction pharmaceutical drug in the US and Europe to capitalise on this huge, unmet market need. Our pipeline includes one drug in phase 3 clinical development, two drugs in phase 2 clinical development and numerous pre-clinical candidates.

Part of City of Tianjin (China), Tianjin Tianduan Press Co., Ltd. is a Chinese company located in Tianjin. The firm manufactures presses. It was founded in 1956. On December 31, 2012 Tianjin Taikang Industrial Co. Ltd. acquired Tianjin Tianduan Press Co., Ltd. from Tianjin BENEFO Machinery Equipment Group Co. Ltd. for $73.04 million.

Sinfonia Biotherapeutics is pioneering the development of novel, bioreactor-delivered drug treatments for familial & genetically-defined orphan neurodegenerative disorders within frontotemporal lobar dementia (FTD), Alzheimer’s and Parkinson’s disorders. Just as cancer is composed of many different subtypes, they know dementia is as well. Thus, to succeed where others have failed in developing dementia treatments, they are developing breakthrough biologic therapies that target familial dementia subtypes with underlying disease mechanisms that are known.

Peking Union Medical College Hospital, also known as Beijing Xiehe Hospital (Chinese: 北京协和医院), is a renowned general hospital in Beijing, China. It was founded in 1921 by Rockefeller Foundation and is affiliated to both Peking Union Medical College (PUMC) and Chinese Academy of Medical Sciences (CAMS). During the Cultural Revolution, it was renamed the "Anti-imperialist Hospital".

Shanghai East Hospital is a Chinese private company located in Shanghai. The firm operates hospital.

Shandong Shanda Affiliated Reproductive Hospital Co., Ltd., established on 2010-01-26, The scope of business includes surgery within the scope of license approval,Obstetrics and Gynecology,Anesthesiology,Medical Laboratory,medical imaging,Diagnosis and treatment services of Chinese medicine department;Human Assisted Reproductive Technology and Human Sperm Bank Training.(The validity period is subject to the license).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Tianjin First Central Hospital (Chinese: 天津市第一中心医院) is a hospital in the Chinese metropolis of Tianjin. In addition to other medical services and teaching, it is a major center for liver transplants. It was founded in 1949.

Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI) and other disorders of the nervous system. The first product for which the Company completed clinical development, Ampyra (dalfampridine) Extended Release Tablets (Ampyra), was approved by the United States Food and Drug Administration (FDA) in January 2010, as a treatment to improve walking in patients with MS. Ampyra is an extended-release tablet formulation of dalfampridine (4-aminopyridine (4-AP)), which was previously referred to as fampridine. Acorda's marketed product, Zanaflex Capsules, is approved by the FDA as a short-acting drug for the management of spasticity.

Qingdao Haicheng Intellectual Property Co., Ltd., established on 2016-01-25, Business scope includes intellectual property information consulting,Intellectual Property Agency Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals. Mitsubishi Tanabe Pharma contribute to the healthier lives of people around the world through the creation of pharmaceuticals.” In accordance with this philosophy, as we implement our business activities we strive to realize our vision, which expresses that “Mitsubishi Tanabe Pharma strive to be a global research-driven pharmaceutical company that is trusted by communities.” As a company that is trusted and highly evaluated by patients and health care professionals as well as by society and shareholders, we will implement management with a focus on transparency and fairness while always keeping in mind the starting point of our business activities: “Everything we do is for the patients.”